AveXis created a revolutionary cure for babies with a deadly disease. But in the hurry to fulfill the drug’s promise, it made mistakes.
The startup had something incredible: a cure for babies with a deadly neurological disease. Last year, the company was snapped up by pharmaceutical giant Novartis AG, and by this past May, its drug was the most expensive on the market.
In just a few years, the company, AveXis Inc., morphed from a handful of hospital-based researchers into one of the pharmaceutical industry’s most stunning success stories.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WeWork Forges On with IPO as Analysts Fear Contagion EffectWeWork’s potential IPO appears to be in free-fall—and it could could “take the air” out of the stock market as a whole
Consulte Mais informação »
The iPhone 11 Pro Max is the heaviest iPhone yet at a whopping half poundThe iPhone 11 Pro Max is 66% heavier than the original iPhone that dropped in 2007, which weighed just 4.8 ounces.
Consulte Mais informação »
Invisalign just conducted a global ad agency review as it looks to ramp up its marketing to fend off rivals like SmileDirectClubThe three largest agency holding companies recently pitched for Invisalign, which risks losing market share to startups including SmileDirectClub.
Consulte Mais informação »
U.S. Consumers Worry but Keep SpendingConsumers are worried but they keep spending. jdlahart explains why this puts the Fed in an awkward position. WSJWhatsNow
Consulte Mais informação »
Why The High Number Of Employees Quitting Reveals A Strong Job MarketWhile recession fears may be looming in the minds of some, new data from the Bureau of Labor Statistics shows that the economy and job market may actually be strengthening.
Consulte Mais informação »